Project BioShield Act of 2004
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Jul 14, 2004 | House · vote #376 | On Passage | Passed | 414–2 | See who voted → |
Project Bioshield Act of 2003 - Permits the Secretary to conduct and support research and development with respect to biomedical countermeasures.
Directs the Secretary, on an ongoing basis, to assess threats of use of chemical, biological, radiological, and nuclear agents and procure biomedical countermeasures to such threats.
Allows the Secretary to declare a national emergency under specified conditions and authorize the release of a drug or device intended solely for use in an emergency.
Improved Vaccine Affordability and Availability Act - Amends the Public Health Service Act to direct the Secretary to: (1) develop and disseminate information concerning certain diseases and their vaccines, including bacterial meningitis and hepatitis A and B; and (2) maintain a six months supply of prioritized vaccines.
Revises provisions governing the National Vaccine Injury Compensation Program, including provisions regarding: (1) equitable relief; (2) derivative petitions; and (3) an extension of the statute of limitations.
Amends Internal Revenue Code provisions concerning the Vaccine Injury Compensation Trust Fund, including to expand compensated loss for injury or death to include related loss.
Amends the Public Health Service Act to require the Secretary to contract with the Institute of Medicine of the National Academy of Science to conduct an ongoing, comprehensive review of new scientific data on childhood vaccines.
Became Public Law No: 108-276.